OBJECTIVE: Structural brain changes appear years before the onset of Alzheimer's disease, the leading cause of dementia late in life. Determining risk factors for such presymptomatic brain changes may assist in identifying candidates for future prevention treatment trials. In addition to the e4 allele of the apolipoprotein E gene (APOE-4), the major known genetic risk factor, a family history of Alzheimer's disease also increases the risk to develop the disease, reflecting yet unidentified genetic and, perhaps, nongenetic risks. The authors investigated the influence of APOE-4 genotype and family history risks on cortical thickness in medial temporal lobe subregions among volunteers without cognitive impairment. METHOD: High-resolution magnetic resonance imaging (MRI) and a cortical unfolding method were performed on 26 subjects (APOE-4 carriers: N=13; noncarriers: N=13) with at least one first-degree relative with Alzheimer's disease and 25 subjects (APOE-4 carriers: N=12; noncarriers: N=13) without this risk factor. All subjects (mean age: 62.3 years [SD=10.7]; range=38-86 years) were cognitively healthy. RESULTS: Family history of Alzheimer's disease and APOE-4 status were associated with a thinner cortex in the entorhinal region, subiculum, and adjacent medial temporal lobe subfields. Although these associations were additive, family history of Alzheimer's disease explained a greater proportion of the unique variance in cortical thickness than APOE-4 carrier status. CONCLUSIONS: APOE-4 carrier status and family history of Alzheimer's disease are independently associated with and contribute additively to hippocampal cortical thinning.
OBJECTIVE: Structural brain changes appear years before the onset of Alzheimer's disease, the leading cause of dementia late in life. Determining risk factors for such presymptomatic brain changes may assist in identifying candidates for future prevention treatment trials. In addition to the e4 allele of the apolipoprotein E gene (APOE-4), the major known genetic risk factor, a family history of Alzheimer's disease also increases the risk to develop the disease, reflecting yet unidentified genetic and, perhaps, nongenetic risks. The authors investigated the influence of APOE-4 genotype and family history risks on cortical thickness in medial temporal lobe subregions among volunteers without cognitive impairment. METHOD: High-resolution magnetic resonance imaging (MRI) and a cortical unfolding method were performed on 26 subjects (APOE-4 carriers: N=13; noncarriers: N=13) with at least one first-degree relative with Alzheimer's disease and 25 subjects (APOE-4 carriers: N=12; noncarriers: N=13) without this risk factor. All subjects (mean age: 62.3 years [SD=10.7]; range=38-86 years) were cognitively healthy. RESULTS: Family history of Alzheimer's disease and APOE-4 status were associated with a thinner cortex in the entorhinal region, subiculum, and adjacent medial temporal lobe subfields. Although these associations were additive, family history of Alzheimer's disease explained a greater proportion of the unique variance in cortical thickness than APOE-4 carrier status. CONCLUSIONS:APOE-4 carrier status and family history of Alzheimer's disease are independently associated with and contribute additively to hippocampal cortical thinning.
Authors: L Adrienne Cupples; Lindsay A Farrer; A Dessa Sadovnick; Norman Relkin; Peter Whitehouse; Robert C Green Journal: Genet Med Date: 2004 Jul-Aug Impact factor: 8.822
Authors: E H Corder; A M Saunders; W J Strittmatter; D E Schmechel; P C Gaskell; G W Small; A D Roses; J L Haines; M A Pericak-Vance Journal: Science Date: 1993-08-13 Impact factor: 47.728
Authors: Eric M Reiman; Kewei Chen; Gene E Alexander; Richard J Caselli; Daniel Bandy; David Osborne; Ann M Saunders; John Hardy Journal: Proc Natl Acad Sci U S A Date: 2003-12-19 Impact factor: 11.205
Authors: A M Saunders; W J Strittmatter; D Schmechel; P H George-Hyslop; M A Pericak-Vance; S H Joo; B L Rosi; J F Gusella; D R Crapper-MacLachlan; M J Alberts Journal: Neurology Date: 1993-08 Impact factor: 9.910
Authors: C M van Duijn; P de Knijff; M Cruts; A Wehnert; L M Havekes; A Hofman; C Van Broeckhoven Journal: Nat Genet Date: 1994-05 Impact factor: 38.330
Authors: O C Okonkwo; G Xu; N M Dowling; B B Bendlin; A Larue; B P Hermann; R Koscik; E Jonaitis; H A Rowley; C M Carlsson; S Asthana; M A Sager; S C Johnson Journal: Neurology Date: 2012-05-16 Impact factor: 9.910
Authors: Davide Bruno; Jay J Nierenberg; James C Ritchie; Michael W Lutz; Nunzio Pomara Journal: Psychoneuroendocrinology Date: 2011-07-30 Impact factor: 4.905
Authors: Ozioma C Okonkwo; Guofan Xu; Jennifer M Oh; N Maritza Dowling; Cynthia M Carlsson; Catherine L Gallagher; Alex C Birdsill; Matthew Palotti; Whitney Wharton; Bruce P Hermann; Asenath LaRue; Barbara B Bendlin; Howard A Rowley; Sanjay Asthana; Mark A Sager; Sterling C Johnson Journal: Cereb Cortex Date: 2012-12-12 Impact factor: 5.357
Authors: Markus Donix; Alison C Burggren; Nanthia A Suthana; Prabha Siddarth; Arne D Ekstrom; Allison K Krupa; Michael Jones; Anup Rao; Laurel Martin-Harris; Linda M Ercoli; Karen J Miller; Gary W Small; Susan Y Bookheimer Journal: Neuroimage Date: 2010-06-10 Impact factor: 6.556
Authors: Dana A Kelly; Michael Seidenberg; Katherine Reiter; Kristy A Nielson; John L Woodard; J Carson Smith; Sally Durgerian; Stephen M Rao Journal: Neuropsychology Date: 2018-06-18 Impact factor: 3.295
Authors: Rebecca L Koscik; Asenath La Rue; Erin M Jonaitis; Ozioma C Okonkwo; Sterling C Johnson; Barbara B Bendlin; Bruce P Hermann; Mark A Sager Journal: Dement Geriatr Cogn Disord Date: 2014-02-20 Impact factor: 2.959
Authors: Liang Wang; Catherine M Roe; Abraham Z Snyder; Matthew R Brier; Jewell B Thomas; Chengjie Xiong; Tammie L Benzinger; John C Morris; Beau M Ances Journal: Ann Neurol Date: 2012-10 Impact factor: 10.422